Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Recursion Pharmaceuticals, Inc. Class A Common Stock

RXRX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of RXRX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
RXRX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
RXRX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RXRX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in RXRX holdings by institutional investors

Quarterly net insider trading by RXRX's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for RXRX

8 former government officials from 7 congressional offices at 1 lobbying firm have lobbied for RXRX, most recently Jul 18, 2025.

  • Nicole Malliotakis
    Alex Bolton House Chief of Staff, Rep. Nicole Malliotakis Formerly with Nicole Malliotakis · ATLAS CROSSING LLC · Jul 18, 2025
  • Jeb Hensarling
    Jennifer Belair House Continued: Rep. Jeb Hensarling; Parliamentarian-Rep. Pete Sessions; Legislative Director-Rep. Doug Collins; Legislative Director/Deputy Parliamentarian/Legislative Clerk/Staff Assistant, House Judiciary Cmte-Rep. Lamar Smith Formerly with Jeb Hensarling · ATLAS CROSSING LLC · Jul 18, 2025
  • Bill Huizenga
    Christopher Kim House Intern, U.S. Rep. Bill Huizenga Formerly with Bill Huizenga · ATLAS CROSSING LLC · Apr 21, 2025
  • Mike Johnson
    Timothy Monahan House Sr. Advisor, Rep. Mike Johnson; Dir. House Operations, Rep. Kevin McCarthy; Staff/Deputy Staff Dir., Comm. on House Admin; Prof Staff, House Approps Comm.; Asst Chief Logistics Officer/Special Asst/Project Mgr House CAO; Dir., CAO IO Operations Formerly with Mike Johnson · ATLAS CROSSING LLC · Oct 18, 2024
  • Lloyd Smucker
    Christopher Eddowes House New Senior Policy Advisor, Congressman Lloyd Smucker Formerly with Lloyd Smucker · ATLAS CROSSING LLC · Aug 03, 2023
  • Patrick T. McHenry
    Sean Joyce House New Chief of Staff, Congressman Patrick McHenry; Legislative Director, Congressman Shuster; Communications Director, Congressman Shuster; Military Legislative Advisor, Congressman Shuster; Senior Legislative Advisor, Congressman Shuster Formerly with Patrick T. McHenry · ATLAS CROSSING LLC · Aug 03, 2023
  • Alexis Oberg Executive New Policy Aide, Office of Governor Nathan Deal Formerly Policy Aide, Office of Governor Nathan Deal · ATLAS CROSSING LLC · Aug 03, 2023
  • Mario Diaz-Balart
    Christopher Sweet House New Deputy Chief of Staff, Legislative Director - Congressman Mario Diaz-Balart Formerly with Mario Diaz-Balart · ATLAS CROSSING LLC · Aug 03, 2023

RXRX Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

RXRX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
RXRX Income Statement
RXRX Balance Sheet
RXRX Cash Flow
U.S. Patents

New RXRX patent grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to RXRX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
RXRX News

Recent insights relating to RXRX

CNBC Recommendations

Recent picks made for RXRX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RXRX

RXRX Analyst Ratings

RXRX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
RXRX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $RXRX stock a Buy, Sell, or Hold?

  • What is the price target for $RXRX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

RXRX Top Shareholders
Shareholder
Shares Held
RXRX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $RXRX stock?

  • Who owns the most shares of $RXRX stock?

  • What funds own $RXRX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RXRX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RXRX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About RXRX

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

  • Address Salt Lake City, UT
  • Market Cap 2.0 billion
  • Employees 600
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Historical Stock Prices

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) closed at $3.74 on September 25, 2026. Over the past year its adjusted close ranged from $2.84 to $6.79. Daily prices go back to April 16, 2021, 1,368 trading days in all.

  • 1 month+7.16%
  • 3 months+6.25%
  • Year to date-8.56%
  • 1 year-19.22%
  • 3 years-50.59%
  • 5 years-84.75%
  • Max-88.05%
See every congressional and insider trade on the RXRX price chart

Quiver Premium charts RXRX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 3.89 3.90 3.70 3.74 3.74 10,481,301
Sep 24, 2026 3.65 3.90 3.61 3.89 3.89 19,338,252
Sep 23, 2026 4.03 4.09 3.66 3.70 3.70 23,670,617
Sep 22, 2026 4.00 4.16 3.90 4.05 4.05 40,460,440
Sep 21, 2026 3.92 4.01 3.83 3.97 3.97 37,728,730
Sep 18, 2026 3.54 3.83 3.50 3.83 3.83 44,325,595
Sep 17, 2026 3.28 3.59 3.26 3.54 3.54 28,251,171
Sep 16, 2026 3.26 3.31 3.16 3.19 3.19 14,813,898
Sep 15, 2026 3.37 3.37 3.22 3.24 3.24 11,881,322
Sep 14, 2026 3.19 3.46 3.18 3.41 3.41 17,102,516
Sep 11, 2026 3.21 3.25 3.15 3.20 3.20 8,034,114
Sep 10, 2026 3.14 3.25 3.10 3.16 3.16 10,625,794
Sep 9, 2026 3.42 3.45 3.21 3.21 3.21 14,198,929
Sep 8, 2026 3.58 3.59 3.43 3.44 3.44 14,990,246
Sep 4, 2026 3.42 3.70 3.41 3.63 3.63 29,039,059
Sep 3, 2026 3.44 3.45 3.29 3.44 3.44 13,746,067
Sep 2, 2026 3.34 3.49 3.29 3.38 3.38 14,052,683
Sep 1, 2026 3.34 3.38 3.28 3.33 3.33 9,996,546
Aug 31, 2026 3.31 3.41 3.25 3.40 3.40 13,911,889
Aug 28, 2026 3.40 3.45 3.31 3.34 3.34 10,560,576
Aug 27, 2026 3.52 3.55 3.42 3.44 3.44 10,986,829
Aug 26, 2026 3.51 3.55 3.43 3.49 3.49 12,978,424
Aug 25, 2026 3.27 3.59 3.26 3.56 3.56 22,516,735
Aug 24, 2026 3.42 3.44 3.21 3.25 3.25 15,155,115
Aug 21, 2026 3.39 3.63 3.37 3.50 3.50 22,898,467
Aug 20, 2026 3.40 3.46 3.27 3.34 3.34 21,453,650
Aug 19, 2026 3.27 3.50 3.19 3.50 3.50 30,369,727
Aug 18, 2026 3.03 3.10 2.92 3.09 3.09 16,348,347
Aug 17, 2026 3.12 3.16 3.08 3.11 3.11 10,621,604
Aug 14, 2026 3.30 3.31 3.14 3.16 3.16 10,545,172
Aug 13, 2026 3.31 3.35 3.27 3.31 3.31 10,699,989
Aug 12, 2026 3.37 3.38 3.26 3.29 3.29 10,305,060
Aug 11, 2026 3.32 3.42 3.27 3.35 3.35 11,008,328
Aug 10, 2026 3.20 3.36 3.19 3.29 3.29 14,034,778
Aug 7, 2026 3.25 3.27 3.18 3.22 3.22 9,355,889
Aug 6, 2026 3.13 3.26 3.12 3.18 3.18 14,794,378
Aug 5, 2026 3.08 3.23 3.01 3.17 3.17 17,458,815
Aug 4, 2026 3.27 3.36 3.21 3.31 3.31 21,577,753
Aug 3, 2026 3.03 3.20 3.00 3.18 3.18 14,721,783
Jul 31, 2026 3.09 3.10 2.95 3.00 3.00 15,329,356
Jul 30, 2026 2.99 3.04 2.95 3.04 3.04 10,409,906
Jul 29, 2026 3.03 3.09 2.94 2.97 2.97 17,954,125
Jul 28, 2026 2.98 3.05 2.86 3.05 3.05 24,398,105
Jul 27, 2026 3.03 3.13 2.99 3.01 3.01 21,724,275
Jul 24, 2026 3.04 3.09 2.92 2.96 2.96 16,530,380
Jul 23, 2026 2.92 3.03 2.92 3.01 3.01 18,832,246
Jul 22, 2026 3.04 3.07 2.97 2.98 2.98 15,209,127
Jul 21, 2026 2.90 3.08 2.90 3.08 3.08 14,868,167
Jul 20, 2026 2.94 2.96 2.84 2.89 2.89 20,807,965
Jul 17, 2026 2.96 3.02 2.93 2.94 2.94 19,353,220
Jul 16, 2026 3.25 3.27 2.98 3.02 3.02 40,174,578
Jul 15, 2026 3.37 3.44 3.28 3.31 3.31 19,429,100
Jul 14, 2026 3.29 3.38 3.21 3.34 3.34 25,658,546
Jul 13, 2026 3.52 3.54 3.27 3.30 3.30 24,497,736
Jul 10, 2026 3.80 3.80 3.44 3.56 3.56 20,808,232
Jul 9, 2026 3.73 3.90 3.69 3.76 3.76 22,293,569
Jul 8, 2026 3.72 3.81 3.63 3.72 3.72 22,705,628
Jul 7, 2026 3.95 4.05 3.81 3.84 3.84 28,855,557
Jul 6, 2026 3.78 4.09 3.66 3.96 3.96 38,065,212
Jul 2, 2026 3.75 3.91 3.70 3.80 3.80 32,680,470
Jul 1, 2026 3.65 4.04 3.61 3.67 3.67 35,726,754
Jun 30, 2026 3.68 3.72 3.57 3.67 3.67 23,159,953
Jun 29, 2026 3.62 3.74 3.55 3.69 3.69 22,932,849
Jun 26, 2026 3.29 3.62 3.28 3.52 3.52 42,587,971
Jun 25, 2026 3.24 3.38 3.19 3.34 3.34 15,633,899
Jun 24, 2026 3.20 3.38 3.16 3.23 3.23 15,504,622
Jun 23, 2026 3.10 3.27 3.09 3.16 3.16 11,169,433
Jun 22, 2026 3.20 3.32 3.11 3.18 3.18 14,444,897
Jun 18, 2026 3.18 3.28 3.11 3.23 3.23 24,853,721
Jun 17, 2026 3.18 3.34 3.07 3.11 3.11 22,173,125
Jun 16, 2026 3.27 3.34 3.16 3.18 3.18 15,477,040
Jun 15, 2026 3.30 3.39 3.23 3.29 3.29 15,393,576
Jun 12, 2026 3.20 3.29 3.12 3.15 3.15 14,837,646
Jun 11, 2026 3.00 3.16 2.95 3.15 3.15 25,424,806
Jun 10, 2026 3.15 3.28 3.03 3.04 3.04 19,534,855
Jun 9, 2026 3.33 3.49 3.13 3.22 3.22 17,850,855
Jun 8, 2026 3.42 3.42 3.28 3.32 3.32 15,796,647
Jun 5, 2026 3.63 3.70 3.21 3.31 3.31 26,943,925
Jun 4, 2026 3.44 4.04 3.44 3.80 3.80 38,926,307
Jun 3, 2026 3.54 3.54 3.37 3.47 3.47 18,499,157
Jun 2, 2026 3.68 3.79 3.57 3.61 3.61 20,861,586
Jun 1, 2026 3.53 3.85 3.45 3.79 3.79 30,989,115
May 29, 2026 3.44 3.68 3.35 3.59 3.59 29,983,555
May 28, 2026 3.10 3.48 3.08 3.44 3.44 24,723,331
May 27, 2026 2.94 3.27 2.90 3.17 3.17 26,463,026
May 26, 2026 3.03 3.14 2.91 2.97 2.97 29,619,806
May 22, 2026 3.10 3.17 2.98 3.01 3.01 14,023,416
May 21, 2026 2.92 3.14 2.88 3.11 3.11 13,174,298
May 20, 2026 2.86 3.00 2.81 2.96 2.96 13,162,530
May 19, 2026 2.87 2.89 2.77 2.85 2.85 16,011,061
May 18, 2026 2.92 2.95 2.82 2.89 2.89 19,169,490
May 15, 2026 3.00 3.05 2.92 2.93 2.93 17,432,058
May 14, 2026 3.13 3.21 3.03 3.04 3.04 15,009,906
May 13, 2026 3.12 3.15 3.05 3.05 3.05 13,643,759
May 12, 2026 3.21 3.23 3.06 3.15 3.15 14,572,495
May 11, 2026 3.24 3.44 3.24 3.26 3.26 14,017,303
May 8, 2026 3.30 3.35 3.20 3.32 3.32 13,648,215
May 7, 2026 3.37 3.52 3.26 3.27 3.27 12,063,436
May 6, 2026 3.19 3.44 3.14 3.43 3.43 17,691,358
May 5, 2026 3.52 3.56 3.32 3.37 3.37 13,484,742
May 4, 2026 3.40 3.55 3.39 3.52 3.52 10,360,005
May 1, 2026 3.46 3.50 3.36 3.39 3.39 12,297,993
Apr 30, 2026 3.33 3.59 3.27 3.46 3.46 13,200,199
Apr 29, 2026 3.37 3.39 3.20 3.30 3.30 12,199,479
Apr 28, 2026 3.43 3.50 3.38 3.41 3.41 8,921,846
Apr 27, 2026 3.46 3.59 3.44 3.48 3.48 10,968,119
Apr 24, 2026 3.50 3.57 3.46 3.51 3.51 9,351,089
Apr 23, 2026 3.69 3.71 3.43 3.50 3.50 11,271,106
Apr 22, 2026 3.62 3.73 3.61 3.73 3.73 10,281,978
Apr 21, 2026 3.70 3.74 3.55 3.56 3.56 11,887,805
Apr 20, 2026 3.71 3.80 3.66 3.69 3.69 9,830,107
Apr 17, 2026 3.74 3.88 3.71 3.78 3.78 14,319,041
Apr 16, 2026 3.85 3.90 3.53 3.60 3.60 16,375,625
Apr 15, 2026 3.57 3.75 3.56 3.75 3.75 12,882,920
Apr 14, 2026 3.49 3.55 3.46 3.54 3.54 9,066,840
Apr 13, 2026 3.25 3.43 3.23 3.42 3.42 8,786,873
Apr 10, 2026 3.32 3.38 3.24 3.28 3.28 8,619,073
Apr 9, 2026 3.33 3.44 3.27 3.31 3.31 8,765,994
Apr 8, 2026 3.39 3.46 3.29 3.39 3.39 15,676,952
Apr 7, 2026 3.12 3.20 3.04 3.19 3.19 10,453,900
Apr 6, 2026 3.12 3.22 3.11 3.15 3.15 8,413,536
Apr 2, 2026 2.94 3.13 2.93 3.11 3.11 9,290,549
Apr 1, 2026 3.13 3.21 3.04 3.06 3.06 10,859,731
Mar 31, 2026 2.90 3.07 2.90 3.07 3.07 13,923,318
Mar 30, 2026 2.93 2.94 2.80 2.84 2.84 16,863,782
Mar 27, 2026 3.09 3.12 2.91 2.94 2.94 19,287,357
Mar 26, 2026 3.10 3.26 3.10 3.15 3.15 9,541,275
Mar 25, 2026 3.21 3.29 3.11 3.17 3.17 13,551,584
Mar 24, 2026 3.20 3.21 3.08 3.17 3.17 13,167,412
Mar 23, 2026 3.25 3.33 3.22 3.23 3.23 11,203,331
Mar 20, 2026 3.35 3.42 3.21 3.25 3.25 26,878,031
Mar 19, 2026 3.23 3.45 3.21 3.37 3.37 11,311,254
Mar 18, 2026 3.41 3.50 3.30 3.32 3.32 14,500,295
Mar 17, 2026 3.39 3.48 3.36 3.42 3.42 10,603,913
Mar 16, 2026 3.45 3.50 3.37 3.39 3.39 10,458,265
Mar 13, 2026 3.35 3.52 3.35 3.42 3.42 14,409,875
Mar 12, 2026 3.40 3.40 3.22 3.29 3.29 18,345,406
Mar 11, 2026 3.44 3.56 3.34 3.45 3.45 14,397,881
Mar 10, 2026 3.49 3.57 3.40 3.44 3.44 10,074,027
Mar 9, 2026 3.33 3.54 3.29 3.51 3.51 12,799,010
Mar 6, 2026 3.47 3.53 3.38 3.46 3.46 12,183,792
Mar 5, 2026 3.55 3.68 3.46 3.54 3.54 14,054,500
Mar 4, 2026 3.60 3.76 3.53 3.64 3.64 16,256,028
Mar 3, 2026 3.46 3.61 3.44 3.54 3.54 12,569,243
Mar 2, 2026 3.48 3.71 3.46 3.63 3.63 14,003,594
Feb 27, 2026 3.65 3.72 3.57 3.67 3.67 14,612,382
Feb 26, 2026 3.68 3.79 3.57 3.77 3.77 16,934,972
Feb 25, 2026 3.91 4.08 3.75 3.77 3.77 44,549,853
Feb 24, 2026 3.39 3.60 3.38 3.53 3.53 15,892,606
Feb 23, 2026 3.40 3.56 3.33 3.41 3.41 14,500,912
Feb 20, 2026 3.64 3.70 3.38 3.42 3.42 18,917,462
Feb 19, 2026 3.46 3.73 3.44 3.72 3.72 20,317,867
Feb 18, 2026 3.06 3.54 2.98 3.53 3.53 38,592,815
Feb 17, 2026 3.48 3.49 3.31 3.46 3.46 17,316,004
Feb 13, 2026 3.60 3.72 3.45 3.49 3.49 16,160,951
Feb 12, 2026 3.74 3.75 3.49 3.58 3.58 19,051,483
Feb 11, 2026 3.87 3.88 3.64 3.71 3.71 24,045,249
Feb 10, 2026 4.00 4.09 3.84 3.85 3.85 11,126,708
Feb 9, 2026 3.95 4.00 3.85 3.98 3.98 14,183,599
Feb 6, 2026 3.74 4.02 3.69 3.98 3.98 26,273,070
Feb 5, 2026 3.79 3.88 3.54 3.56 3.56 40,627,163
Feb 4, 2026 4.12 4.12 3.71 3.90 3.90 36,835,887
Feb 3, 2026 4.21 4.29 3.96 4.10 4.10 23,496,485
Feb 2, 2026 4.12 4.26 4.08 4.18 4.18 17,443,762
Jan 30, 2026 4.26 4.34 4.16 4.19 4.19 19,769,397
Jan 29, 2026 4.44 4.48 4.30 4.32 4.32 17,455,930
Jan 28, 2026 4.64 4.64 4.42 4.47 4.47 16,212,547
Jan 27, 2026 4.64 4.74 4.49 4.60 4.60 15,855,816
Jan 26, 2026 4.71 4.72 4.55 4.59 4.59 15,464,195
Jan 23, 2026 4.90 4.96 4.70 4.73 4.73 18,328,708
Jan 22, 2026 4.65 5.24 4.62 4.96 4.96 36,434,591
Jan 21, 2026 4.42 4.67 4.35 4.61 4.61 26,949,524
Jan 20, 2026 4.46 4.55 4.39 4.40 4.40 22,287,771
Jan 16, 2026 4.65 4.88 4.55 4.67 4.67 21,430,673
Jan 15, 2026 4.85 4.87 4.63 4.64 4.64 19,182,745
Jan 14, 2026 4.62 4.87 4.61 4.85 4.85 16,954,817
Jan 13, 2026 4.88 4.96 4.63 4.69 4.69 18,996,434
Jan 12, 2026 4.76 4.98 4.72 4.81 4.81 24,699,486
Jan 9, 2026 4.78 4.82 4.62 4.66 4.66 15,381,319
Jan 8, 2026 4.79 4.79 4.65 4.70 4.70 17,187,200
Jan 7, 2026 4.55 5.00 4.54 4.86 4.86 33,116,675
Jan 6, 2026 4.36 4.66 4.35 4.55 4.55 23,178,027
Jan 5, 2026 4.26 4.42 4.25 4.37 4.37 17,617,871
Jan 2, 2026 4.17 4.23 4.12 4.20 4.20 16,227,218
Dec 31, 2025 4.10 4.14 4.05 4.09 4.09 15,217,373
Dec 30, 2025 4.15 4.21 4.10 4.11 4.11 18,023,774
Dec 29, 2025 4.18 4.31 4.11 4.13 4.13 24,567,479
Dec 26, 2025 4.41 4.41 4.23 4.25 4.25 15,948,619
Dec 24, 2025 4.35 4.43 4.30 4.40 4.40 9,422,190
Dec 23, 2025 4.33 4.39 4.18 4.36 4.36 26,035,973
Dec 22, 2025 4.36 4.53 4.30 4.40 4.40 24,628,968
Dec 19, 2025 4.51 4.53 4.25 4.26 4.26 55,008,582
Dec 18, 2025 4.76 4.96 4.44 4.44 4.44 31,684,776
Dec 17, 2025 4.51 5.01 4.48 4.68 4.68 65,554,807
Dec 16, 2025 4.16 4.33 4.14 4.20 4.20 13,617,214
Dec 15, 2025 4.34 4.36 4.14 4.20 4.20 17,415,058
Dec 12, 2025 4.57 4.64 4.31 4.33 4.33 17,978,296
Dec 11, 2025 4.70 4.80 4.57 4.58 4.58 13,575,788
Dec 10, 2025 4.76 4.91 4.66 4.77 4.77 13,683,591
Dec 9, 2025 4.73 4.91 4.61 4.77 4.77 17,743,325
Dec 8, 2025 4.97 5.09 4.68 4.82 4.82 34,939,565
Dec 5, 2025 4.87 4.88 4.67 4.71 4.71 17,128,101
Dec 4, 2025 4.63 4.94 4.58 4.92 4.92 19,905,580
Dec 3, 2025 4.37 4.67 4.33 4.66 4.66 19,822,340
Dec 2, 2025 4.37 4.52 4.31 4.32 4.32 17,620,915
Dec 1, 2025 4.46 4.54 4.36 4.36 4.36 18,257,371
Nov 28, 2025 4.46 4.64 4.40 4.63 4.63 10,570,783
Nov 26, 2025 4.38 4.48 4.30 4.41 4.41 17,253,191
Nov 25, 2025 4.28 4.41 4.18 4.37 4.37 16,245,921
Nov 24, 2025 4.20 4.35 4.14 4.33 4.33 17,701,758
Nov 21, 2025 3.91 4.26 3.85 4.17 4.17 33,632,386
Nov 20, 2025 4.15 4.37 3.81 3.85 3.85 38,835,975
Nov 19, 2025 4.16 4.22 3.98 4.03 4.03 27,836,683
Nov 18, 2025 4.03 4.25 3.96 4.16 4.16 25,782,965
Nov 17, 2025 4.13 4.28 4.01 4.12 4.12 24,751,306
Nov 14, 2025 4.17 4.38 4.13 4.14 4.14 31,415,419
Nov 13, 2025 4.54 4.61 4.30 4.33 4.33 25,689,874
Nov 12, 2025 4.72 4.80 4.54 4.65 4.65 23,549,351
Nov 11, 2025 4.51 4.77 4.46 4.71 4.71 24,526,112
Nov 10, 2025 4.89 4.96 4.47 4.51 4.51 33,369,567
Nov 7, 2025 4.50 4.64 4.18 4.62 4.62 52,638,145
Nov 6, 2025 4.98 4.99 4.60 4.62 4.62 38,326,840
Nov 5, 2025 5.07 5.20 4.86 4.96 4.96 57,423,883
Nov 4, 2025 5.20 5.32 4.97 5.00 5.00 43,371,830
Nov 3, 2025 5.57 5.76 5.33 5.44 5.44 48,329,771
Oct 31, 2025 5.70 5.74 5.41 5.52 5.52 43,304,094
Oct 30, 2025 5.68 5.84 5.63 5.65 5.65 33,371,609
Oct 29, 2025 5.99 6.10 5.68 5.87 5.87 43,607,060
Oct 28, 2025 6.22 6.25 5.85 5.91 5.91 38,643,347
Oct 27, 2025 6.15 6.50 5.93 6.30 6.30 55,252,527
Oct 24, 2025 5.94 6.15 5.72 6.04 6.04 39,056,755
Oct 23, 2025 5.74 5.89 5.63 5.73 5.73 35,164,417
Oct 22, 2025 6.07 6.31 5.58 5.75 5.75 45,277,043
Oct 21, 2025 6.66 6.70 6.00 6.11 6.11 58,243,151
Oct 20, 2025 6.22 7.18 6.21 6.68 6.68 90,054,902
Oct 17, 2025 6.15 6.25 5.81 5.86 5.86 70,191,164
Oct 16, 2025 6.79 7.04 6.25 6.36 6.36 229,692,510
Oct 15, 2025 6.05 6.82 6.01 6.79 6.79 180,161,285
Oct 14, 2025 5.32 6.00 5.07 5.89 5.89 104,026,796
Oct 13, 2025 5.52 5.57 5.25 5.53 5.53 57,007,817
Oct 10, 2025 6.04 6.20 5.30 5.32 5.32 60,530,345
Oct 9, 2025 6.14 6.18 5.71 5.91 5.91 51,030,141
Oct 8, 2025 5.25 6.30 5.19 6.09 6.09 94,203,504
Oct 7, 2025 5.55 5.60 5.11 5.23 5.23 34,119,741
Oct 6, 2025 5.60 5.70 5.50 5.53 5.53 34,740,553
Oct 3, 2025 5.60 5.70 5.34 5.49 5.49 49,126,391
Oct 2, 2025 5.21 5.61 5.12 5.52 5.52 58,334,730
Oct 1, 2025 4.83 5.23 4.80 5.10 5.10 43,900,031
Sep 30, 2025 4.85 4.88 4.73 4.88 4.88 28,881,822
Sep 29, 2025 4.78 5.00 4.70 4.91 4.91 40,995,497
Sep 26, 2025 4.62 4.73 4.57 4.72 4.72 39,343,165
Sep 25, 2025 4.76 4.82 4.58 4.63 4.63 47,211,859

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Recursion Pharmaceuticals, Inc. Class A Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at RXRX, per a recent SEC DEF 14A filing. We estimate that the median employee at RECURSION PHARMACEUTICALS, INC. is paid $300,991.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation